New technology allows users to view a day-in-the-life of someone living with MS
TORONTO, May 31, 2017/CNW/ - EMD Serono, Canada, a biopharmaceutical business of Merck KGaA Darmstadt, Germany, is using cutting-edge virtual reality (VR) technology to educate Canadians about Multiple Sclerosis
"This is a big first step for technology integration in the MS space and we're excited about the possibilities it may provide the 100,000 Canadians currently living with the disease," says Gaby Murphy, President and Managing Director, EMD Serono, Canada. "EMD Serono, Canada is committed to furthering education about MS for both people with the disease and their loved ones. This ground-breaking technology has potential to help increase our understanding of MS and further raise awareness of the impact of the disease."
VR is changing the way we understand and communicate issues around the world, and this innovation has become especially important within healthcare. MS from the Inside Out seeks to break down barriers of the invisible aspects of the disease and its complex symptoms.
"The effects of MS can be physical and emotional, and because its symptoms are often invisible, the experiences of those suffering from MS can be difficult for caregivers, family and friends to understand," says Dr. Daniel Selchen, Director, MS Clinic, St. Michael's Hospital, Toronto. "Knowing that, raising awareness of MS is critical, and gaining insight into the journey a person living with MS faces allows us to further understand this complex disease."
To coincide with World MS Day, EMD Serono, Canada held an event at the MaRS Discovery District in Toronto, during which people were able to immerse themselves in the MS VR experience, gaining deeper insights into the impact of the disease. EMD Serono has captured people's experiences with this technology in a video you can view here.
EMD Serono encourages Canadians to help spread the word and raise awareness of MS by viewing and sharing the YouTube video.
About Multiple Sclerosis
Multiple Sclerosis (MS) is a degenerative auto-immune disease in which the myelin sheath around the nerves in the brain and spinal cord are inflamed and often damaged.2 It is estimated that approximately 2.3 million people have MS worldwide.3 Canada has one of the highest prevalence rates of MS in the world.4 Currently, there are an estimated 100,000 Canadians living with MS.4 Symptoms of MS can include extreme fatigue, lack of coordination, weakness, tingling, impaired sensation, vision problems, bladder problems, cognitive impairment and mood changes.5 Currently there is no cure, but each day researchers are learning more about what causes MS and are zeroing in on ways to prevent it.6
About EMD Serono, Canada
EMD Serono, Canada, is the Canadian biopharmaceutical business of Merck KGaA, Darmstadt, Germany. EMD Serono, Canada has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and access programs. EMD Serono, Canada has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in neurology, oncology, immunology and immuno-oncology. Today, EMD Serono, Canada has more than 100 employees across Canada with headquarters in Mississauga, Ontario.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck KGaA, Darmstadt, Germany generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, Millipore Sigma and EMD Performance Materials.
References______________________1 MS Society of Canada. What is MS. Accessed May 16, 2017. Available at https://mssociety.ca/about-ms/what-is-ms2 Ibid.3 National MS Society. What is MS. Accessed May 16, 2017. Available at http://www.nationalmssociety.org/What-is-MS/MS-FAQ-s 4 MS Society of Canada. What is MS. Accessed April 24, 2017. Available at https://mssociety.ca/about-ms/what-is-ms 5 MS Society of Canada. What is MS. Accessed May 16, 2017. Available at https://mssociety.ca/about-ms/what-is-ms6 Ibid.
SOURCE EMD Inc.
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All